Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Non-Current Assets (2017 - 2026)

Sunshine Biopharma filings provide 4 years of Other Non-Current Assets readings, the most recent being $7590.0 for Q4 2020.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $7590.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $7590.0, a N/A change, with the full-year FY2020 number at $7590.0, changed N/A from a year prior.
  • Other Non-Current Assets hit $7590.0 in Q4 2020 for Sunshine Biopharma, down from $989572.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $989572.0 in Q4 2018 to a low of $7590.0 in Q4 2020.
  • Median Other Non-Current Assets over the past 4 years was $534931.0 (2017), compared with a mean of $510725.3.
  • Biggest five-year swings in Other Non-Current Assets: surged 1132.5% in 2018 and later surged 12658.79% in 2019.
  • Sunshine Biopharma's Other Non-Current Assets stood at $80290.0 in 2017, then surged by 1132.5% to $989572.0 in 2018, then changed by 0.0% to $989572.0 in 2019, then plummeted by 99.23% to $7590.0 in 2020.
  • The last three reported values for Other Non-Current Assets were $7590.0 (Q4 2020), $989572.0 (Q2 2019), and $989572.0 (Q1 2019) per Business Quant data.